We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MDT icon
301
Medtronic
MDT
$132B
$308K 0.01%
+3,810
New +$305K
2017 Q4
0 quarters
RTX icon
302
RTX
RTX
$267B
$288K 0.01%
+3,582
New +$272K
2017 Q4
0 quarters
HUN icon
303
Huntsman
HUN
$1.67B
$280K 0.01%
8,425
-268,537
-97% -$8.22M
2017 Q2
2 quarters
LKFT icon
304
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.29B
$279K 0.01%
+2,979
New +$282K
2017 Q4
0 quarters
WM icon
305
Waste Management
WM
$97.4B
$266K 0.01%
+3,082
New +$251K
2017 Q4
0 quarters
LNT icon
306
Alliant Energy
LNT
$19.1B
$261K 0.01%
+6,114
New +$266K
2017 Q4
0 quarters
SYY icon
307
Sysco
SYY
$38.3B
$255K 0.01%
+4,192
New +$238K
2017 Q4
0 quarters
RAD
308
DELISTED
Rite Aid
RAD
$255K 0.01%
6,468
-72
-1% -$2.57K
2016 Q1
7 quarters
SAEX
309
DELISTED
SAExploration Holdings
SAEX
$252K 0.01%
5,737
– –
2013 Q4
16 quarters
LEA icon
310
Lear
LEA
$5.21B
$247K 0.01%
1,400
-2,598
-65% -$456K
2015 Q3
9 quarters
OCLR
311
DELISTED
Oclaro
OCLR
$236K 0.01%
35,000
+10,000
+40% +$73.9K
2017 Q2
2 quarters
NMRK icon
312
Newmark Group
NMRK
$1.91B
$233K 0.01%
+14,679
New +$225K
2017 Q4
0 quarters
ACFC
313
DELISTED
Atlantic Coast Financial
ACFC
$228K 0.01%
+24,148
New +$218K
2017 Q4
0 quarters
AAOI icon
314
Applied Optoelectronics
AAOI
$4.22B
$208K 0.01%
5,500
+2,750
+100% +$121K
2017 Q3
1 quarter
NEE icon
315
NextEra Energy
NEE
$180B
$206K 0.01%
+5,280
New +$204K
2017 Q4
0 quarters
NWL icon
316
Newell Brands
NWL
$2.5B
$205K 0.01%
+6,624
New +$228K
2017 Q4
0 quarters
VRSK icon
317
Verisk Analytics
VRSK
$27B
$201K 0.01%
+2,096
New +$190K
2017 Q4
0 quarters
LEU icon
318
Centrus Energy
LEU
$2.12B
$197K 0.01%
49,203
-40,521
-45% -$164K
2014 Q3
13 quarters
JNJ icon
319
Johnson & Johnson
JNJ
$692B
$196K 0.01%
+1,402
New +$195K
2017 Q4
0 quarters
PBCT
320
DELISTED
People's United Financial
PBCT
$194K 0.01%
+10,401
New +$193K
2017 Q4
0 quarters
C.WS.A icon
321
DELISTED
Citigroup
C.WS.A
$186K 0.01%
1,856,253
-27,704
-1% -$3.12K
2013 Q2
18 quarters
PDCO icon
322
DELISTED
Patterson Companies
PDCO
$184K 0.01%
+5,097
New +$186K
2017 Q4
0 quarters
ABBV icon
323
AbbVie
ABBV
$527B
$183K 0.01%
1,890
-1,471
-44% -$139K
2017 Q3
1 quarter
T icon
324
AT&T
T
$151B
$178K 0.01%
+6,052
New +$165K
2017 Q4
0 quarters
PRGX
325
DELISTED
PRGX Global
PRGX
$169K 0.01%
+23,777
New +$173K
2017 Q4
0 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo, cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.